Japanese drugmakers slump after Trump unveils discount drug website
TOKYO, Feb 6 (Reuters) - Shares of Japanese pharmaceutical companies slumped in early Tokyo trading on Friday after U.S. President Donald Trump's website offering discounted prescription medicines went live.
Sumitomo Pharma sank 4.5%, while Roche affiliate Chugai Pharmaceutical lost 3.1%. Takeda Pharmaceutical, Japan's largest drugmaker, declined 1.5%.
Trump on Thursday unveiled TrumpRx.gov following deals struck with 16 of the largest global drugmakers for "most-favoured nation" prices for Americans in exchange for exemptions from U.S. tariffs.
The drugmaker sector lost 1.6% to become the second-worst performer among the Tokyo Stock Exchange's 33 industry sub-indexes.
(Reporting by Rocky Swift in Tokyo; Editing by Sherry Jacob-Phillips)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Corporate Power Reshapes Bitcoin’s Decentralized Legacy
Eaton Advances to 191st Place in Trading Volume Driven by Strong Earnings and Robust Growth Plan
Q4 Financial Overview: Comparing Procter & Gamble (NYSE:PG) With Other Household Product Companies
Great Elm Capital: Fourth Quarter Earnings Overview
Trending news
MoreCrypto prices
More
